FN Archimer Export Format
PT J
TI Marine versus Non-Marine Bacterial Exopolysaccharides and Their Skincare Applications
BT 
AF Benhadda, Fanny
   Zykwinska, Agata
   Colliec-Jouault, Sylvia
   Sinquin, Corinne
   Thollas, Bertrand
   Courtois, Anthony
   Fuzzati, Nicola
   Toribio, Alix
   Delbarre-Ladrat, Christine
AS 1:1,2;2:1;3:1;4:1;5:3;6:3;7:2;8:2;9:1;
FF 1:;2:PDG-RBE-MASAE-LEMMMB;3:PDG-RBE-MASAE-LEMMMB;4:PDG-RBE-MASAE-LEMMMB;5:;6:;7:;8:;9:PDG-RBE-MASAE-LEMMMB;
C1 Ifremer, MASAE Microbiologie Aliment Santé Environnement, F-44000 Nantes, France
   CHANEL Fragrance and Beauty, F-93500 Pantin, France
   Polymaris Biotechnology, F-29200 Brest, France
C2 IFREMER, FRANCE
   CHANEL, FRANCE
   POLYMARIS BIOTECHNOLOGY, FRANCE
SI NANTES
SE PDG-RBE-MASAE-LEMMMB
IN WOS Ifremer UPR
   DOAJ
   copubli-france
IF 5.4
TC 3
UR https://archimer.ifremer.fr/doc/00860/97150/105982.pdf
LA English
DT Article
DE ;marine bacterial exopolysaccharides;biotechnology;cosmetic industry
AB Bacteria are well-known to synthesize high molecular weight polysaccharides excreted in extracellular domain, which constitute their protective microenvironment. Several bacterial exopolysaccharides (EPS) are commercially available for skincare applications in cosmetic products due to their unique structural features, conferring valuable biological and/or textural properties. This review aims to give an overview of bacterial EPS, an important group of macromolecules used in cosmetics as actives and functional ingredients. For this purpose, the main chemical characteristics of EPS are firstly described, followed by the basics of the development of cosmetic ingredients. Then, a focus on EPS production, including upstream and downstream processes, is provided. The diversity of EPS used in the cosmetic industry, and more specifically of marine-derived EPS is highlighted. Marine bacteria isolated from extreme environments are known to produce EPS. However, their production processes are highly challenging due to high or low temperatures; yield must be improved to reach economically viable ingredients. The biological properties of marine-derived EPS are then reviewed, resulting in the highlight of the challenges in this field. 
PY 2023
PD NOV
SO Marine Drugs
SN 1660-3397
PU MDPI AG
VL 21
IS 11
UT 001113633700001
DI 10.3390/md21110582
ID 97150
ER

EF